Posted on 11/12/20
North Easton Savings Bank Completes Third “A World for Good” Community Nonprofit Voting Campaign
$5,000 donated across six community-focused organizations North Easton Savings Bank recently announced the successful conclusion of its third “A World for Good” community nonprofit voting campaign. . . .
Posted on 11/12/20
Despite Declining Earnings And Revenue, Nuance Communications Has Rallied Sharply
Nuance saw its stock rally over 160% off its March low and it did so in a very steady and organized manner.The company is set to . . .
Posted on 11/12/20
Pulse Technology Receives 2020 Elite Dealer Award
For the 14th year in a row, Pulse Technology has been selected as an Elite Dealer Award by ENX Magazine/The Week in Imaging, a national magazine which recognizes . . .
Posted on 11/12/20
Inozyme Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of . . .
Posted on 11/12/20
TCR Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for . . .
Posted on 11/12/20
H.I.G. Capital Portfolio Company Eze Castle Integration Acquires NorthOut
BOSTON--(BUSINESS WIRE)--H.I.G. Capital, a leading global alternative investment firm with over $41 billion of equity capital under management, is pleased to announce that its portfolio company, . . .
Posted on 11/12/20
Akouos Reports Third Quarter 2020 Financial Results and Provides Business Highlights
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Akouos, Inc. (Nasdaq: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with . . .
Posted on 11/12/20
BioXcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
NEW HAVEN, Conn., Nov. 12, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience . . .
Posted on 11/12/20
iTeos Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass. and GOSSELIES, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of . . .
Posted on 11/12/20
Foghorn Therapeutics Appoints Michael LaCascia as Chief Legal Officer
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines . . .
Posted on 11/12/20
SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
STAMFORD, Conn., Nov. 12, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 11/12/20
Reprise Closes $3.2 Million in Seed Funding
Reprise, the demo creation platform company, today emerged from stealth and announced its $3.2 million seed round, co-led by Glasswing Ventures and Accomplice Ventures.
Posted on 11/12/20
Madison Realty Capital Originates $50 Million Loan for Luxury Rental Apartment Building in Pompano Beach, Florida
New York, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Madison Realty Capital, a New York City based real estate private equity firm focused on debt and equity . . .
Posted on 11/12/20
What To Do After Raytheon Technologies Soared 19%
SummaryRaytheon's post-earnings slump in the low $52 range created a good entry point for value investors.Strong cash flow increasing in 2021.Price target of over $90.00 explained.I . . .
Posted on 11/12/20
iTeos Appoints Matthew Roden, Ph.D. to Board
iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development
Posted on 11/12/20
IDEXX Laboratories Appoints Dr. Asha S. Collins to Board
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today the election of Dr. Asha S. . . .
Posted on 11/12/20
DRIVE by DraftKings Appoints Meredith McPherron as CEO
DRIVE by DraftKings has appointed Meredith McPherron as its CEO and Managing Partner. DRIVE, a multi-stage venture capital firm that invests in SportsTech and Entertainment
Posted on 11/12/20
GE Ends Century-Old Development Program
In the midst of a multiyear turnaround plan, General Electric (NYSE:GE) is ending a more than 100-year-old employee development program, according to a Wall Street Journal . . .
Posted on 11/12/20
Why Warren Buffett's Riskiest Bet in Years Is on the Brink of Bombing
Warren Buffett isn't exactly viewed as a big gambler. Sure, the Oracle of Omaha takes risks with his investments. For the most part, though, his risks . . .
Posted on 11/12/20
Warren Buffett Spent Billions on Stocks in Q3
We recently got a look at Berkshire Hathaway's (NYSE:BRK-A)(NYSE:BRK-B) third-quarter earnings report, and we learned quite a bit about how the conglomerate is doing. We learned . . .
Posted on 11/12/20
Biogen's Possible Shopping List: 3 Companies the Biotech Might Buy
Biogen (NASDAQ:BIIB) might be in deep trouble. The biotech's core multiple sclerosis franchise has been hit hard by generic competition this year, and its plan to . . .
Posted on 11/12/20
Should Warren Buffett Invest in PayPal?
With some help from his portfolio managers, Warren Buffett's investment strategy has slowly evolved over the years from one favoring value investments to one featuring growth . . .
Posted on 11/12/20
Moderna's Cancer Vaccine Scores in a Clinical Trial
On Wednesday, Moderna (NASDAQ:MRNA) announced encouraging results from a clinical trial with an experimental cancer vaccine. Treatment with the messenger RNA-based candidate, mRNA-4157, shrank tumors for . . .
Posted on 11/12/20
Hub International Acquires The Assets Of Baystate Fiduciary Advisors
HUB International Limited (Hub), a leading full-service global insurance broker, announced today that it has acquired the assets of Baystate Fiduciary Advisors, Inc. (Baystate Fiduciary Advisors). . . .
Posted on 11/12/20
Julie Murchinson Joins Transformation Capital as Partner
Transformation Capital, a leading digital health growth equity firm, today announced that Julie Murchinson has joined the firm as partner. Based in the San Francisco office, . . .

